Bloomberg Businessweek
Trump Tariff Plans Expected to Deliver High Drama, Bumpy Rollout
Nov 12, 2024
Shawn Donnan, a senior economics writer at Bloomberg News, discusses the complexities of Trump’s tariff plans and their uncertain impacts on the U.S. economy. Paul Christopher, Head of Global Investment Strategy at Wells Fargo, shares insights into market trends amid these policy changes. They explore how tariffs could affect American manufacturers, inflation, and even the labor market. The conversation also touches on the evolving landscape of private credit and the cautious investment strategies needed in this dynamic financial environment.
22:16
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The Trump administration's tariff plans may be structured to minimize harm to US businesses, although the specific execution remains uncertain.
- Pagaya Technology's innovative use of AI enables financing access for consumers often overlooked by traditional lenders, emphasizing the rise of private credit.
Deep dives
Vertex Pharmaceuticals' Innovative Approach
Vertex Pharmaceuticals is leveraging unique tools and methods to tackle some of the most challenging diseases facing humanity. The company is focused on precision medicine, specifically targeting diseases with known causes through specific treatment solutions. By using advanced research techniques and a comprehensive understanding of disease mechanisms, Vertex aims to develop tailored therapies that improve patient outcomes. Their commitment to innovation has positioned them as a leader in the pharmaceutical industry in the quest for effective treatments.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
